Philipp Lehr

554 total citations
16 papers, 390 citations indexed

About

Philipp Lehr is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Philipp Lehr has authored 16 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Infectious Diseases and 7 papers in Organic Chemistry. Recurrent topics in Philipp Lehr's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (4 papers) and Estrogen and related hormone effects (4 papers). Philipp Lehr is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (4 papers) and Estrogen and related hormone effects (4 papers). Philipp Lehr collaborates with scholars based in Austria, Germany and Switzerland. Philipp Lehr's co-authors include Andreas Billich, Peter Nußbaumer, Ulrich Schöllkopf, Brigitte Rosenwirth, Hubert Gstach, Dieter Scholz, Brigitte Charpiot, Peter Ettmayer, Barbara Wolff and Erwin Schreiner and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Synthesis.

In The Last Decade

Philipp Lehr

16 papers receiving 374 citations

Peers

Countries citing papers authored by Philipp Lehr

Since Specialization

Citations

This map shows the geographic impact of Philipp Lehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Lehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Lehr more than expected).

Fields of papers citing papers by Philipp Lehr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Lehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Lehr. The network helps show where Philipp Lehr may publish in the future.

Co-authorship network of co-authors of Philipp Lehr

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp Lehr. A scholar is included among the top collaborators of Philipp Lehr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp Lehr. Philipp Lehr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Chronische hepatische Porphyrie mit Uroporphyrinogen-Decarboxylase-Defekt in vier Generationen 2008 ·DMW - Deutsche Medizinische Wochenschrift ·Philipp Lehr, M. Doss	1
2	N-Acyl arylsulfonamides as novel, reversible inhibitors of human steroid sulfatase 2004 ·Bioorganic & Medicinal Chemistry Letters ·Philipp Lehr, Andreas Billich, Barbara Wolff, Peter Nußbaumer	18
3	Nortropinyl-Arylsulfonylureas as novel, reversible inhibitors of human steroid sulfatase 2003 ·Bioorganic & Medicinal Chemistry Letters ·Peter Nußbaumer, Dieter Geyl, (unknown), Philipp Lehr, Barbara Wolff, Andreas Billich	18
4	2-Substituted 4-(Thio)chromenone 6-O-Sulfamates: Potent Inhibitors of Human Steroid Sulfatase 2002 ·Journal of Medicinal Chemistry ·Peter Nußbaumer, Philipp Lehr, Andreas Billich	107
5	Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors 2000 ·The Journal of Steroid Biochemistry and Molecular Biology ·Andreas Billich, Peter Nußbaumer, Philipp Lehr	89
6	Inhibitors of Human Immunodeficiency Virus Type 1 Protease Containing 2-Aminobenzyl-Substituted 4-Amino-3-hydroxy-5-phenylpentanoic Acid: Synthesis, Activity, and Oral Bioavailability 1996 ·Journal of Medicinal Chemistry ·Philipp Lehr, Andreas Billich, Brigitte Charpiot, Peter Ettmayer, Dieter Scholz, Brigitte Rosenwirth, Hubert Gstach	29
7	Potent and Orally Bioavailable HIV-1 Proteinase Inhibitors Containing the 2-aminobenzylstatine Moiety 1995 ·Antiviral chemistry & chemotherapy ·Andreas Billich, Dieter Scholz, Brigitte Charpiot, Hubert Gstach, Philipp Lehr, P. Peichl, Brigitte Rosenwirth	7
8	SDZ PRI 053, an orally bioavailable human immunodeficiency virus type 1 proteinase inhibitor containing the 2-aminobenzylstatine moiety 1995 ·Antimicrobial Agents and Chemotherapy ·Andreas Billich, Gert Fricker, (unknown), P. Donatsch, Peter Ettmayer, Hubert Gstach, Philipp Lehr, P. Peichl, Dieter Scholz, Brigitte Rosenwirth	12
9	HIV proteinase inhibitors containing 2-aminobenzylstatine as a novel scissile bond replacement: biochemical and pharmacological characterization 1994 ·Antiviral Research ·Andreas Billich, Brigitte Charpiot, Gert Fricker, Hubert Gstach, Philipp Lehr, P. Peichl, Dieter Scholz, Brigitte Rosenwirth	8
10	Inhibitors of HIV-1 Proteinase Containing 2-Heterosubstituted 4-Amino-3-hydroxy-5-phenylpentanoic Acid: Synthesis, Enzyme Inhibition, and Antiviral Activity 1994 ·Journal of Medicinal Chemistry ·Dieter Scholz, Andreas Billich, Brigitte Charpiot, Peter Ettmayer, Philipp Lehr, Brigitte Rosenwirth, Erwin Schreiner, Hubert Gstach	44
11	21 New highly potent HIV-1 protease inhibitors 1993 ·Antiviral Research ·Dieter Scholz, (unknown), Brigitte Charpiot, Hubert Gstach, Philipp Lehr, Brigitte Rosenwirth, Andreas Billich	1
12	Kinetic and Binding Studies on [¹²⁵I]SDZ-283471, A Radiolabeled Inhibitor of Hiv-1 Proteinase 1993 ·Journal of enzyme inhibition ·Andreas Billich, (unknown), Philipp Lehr, Brigitte Charpiot, Hubert Gstach, Dieter Scholz	2
13	ChemInform Abstract: ASYMMETRIC SYNTHESIS VIA HETEROCYCLIC INTERMEDIATES, XXIV. ENANTIOSELECTIVE SYNTHESIS OF (R)‐α‐METHYLTRYPTOPHAN METHYL ESTER AND D‐TRYPTOPHAN METHYL ESTER BY THE BISLACTIM ETHER ROUTE 1985 ·Chemischer Informationsdienst ·(unknown), (unknown), Philipp Lehr	1
14	Notizen Asymmetric Syntheses via Heterocyclic Intermediates, XXIV. Enantioselective Synthesis of (R)‐α‐Methyltryptophane Methyl Ester and D‐Tryptophane Methyl Ester by the Bislactim Ether Route 1985 ·Liebigs Annalen der Chemie ·Ulrich Schöllkopf, (unknown), Philipp Lehr	33
15	ChemInform Abstract: ASYMMETRIC SYNTHESES VIA HETEROCYCLIC INTERMEDIATES. XXI. ENANTIOSELECTIVE SYNTHESIS OF α‐ALKYLLEUCINE METHYL ESTERS USING THE BISLACTIM ETHER OF CYCLO(L‐LEU‐L‐LEU) AS STARTING MATERIAL 1984 ·Chemischer Informationsdienst ·(unknown), (unknown), (unknown), Philipp Lehr	3
16	Asymmetric Syntheses via Heterocyclic Intermediates; XXI¹. Enantioselective Synthesis of α-Alkylleucine Methyl Esters using the Bis-lactim Ether of Cyclo(L-Leu-L-Leu) as Starting Material 1984 ·Synthesis ·Ulrich Schöllkopf, (unknown), (unknown), Philipp Lehr	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact